What to Disclose and When: SEC Corporate Filing in the Time of COVID-19

May 13, 2020
Fox Rothschild LLP and NSCP

The coronavirus pandemic has presented corporate compliance professionals with unprecedented issues affecting disclosures, filings and other SEC requirements. As the deadline for submitting Form 10-Qs approaches for non-accelerated filers, understanding the guidance issued by the SEC will be critical to their 10-Q and other periodic filings.

Fox Rothschild’s Securities Industry Practice presents an informative discussion on a variety of compliance topics related to the COVID-19 pandemic. Laura Holm and Jesse Fishman will lead the discussion, covering a range of subjects, including:

  • SEC guidance contained in CF Disclosure Guidance Topic #9 and its impact on forward-looking statements, MD&A and disclosure controls and procedures
  • Filing an extension for additional time to file your Form 10-Q, 10-K and certain other periodic reports
  • Can companies engage in stock buybacks?
  • Is it necessary to disclose if your CEO or other officers have COVID-19?
  • Effects on periodic reports, proxy statements and other information that needs to be disclosed by companies
  • Virtual shareholder meetings

Additional Information